StockData
Lexeo Therapeutics, Inc. logo

Lexeo Therapeutics, Inc. (LXEO) stock

LXEONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$2.95+0.10 (+3.33%)

Close on Nov 18, 2026Market cap $242.04MP/E –Yield –

Lexeo Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Lexeo Therapeutics

Lexeo Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Lexeo Therapeutics figures

See a number that looks wrong?